Now, the nasal spray can be used on its own. “This really makes the therapy so much more accessible to patients,” Haviva Malina, MD, co-founder of the ketamine infusion clinic Keta Medical Center, ...

“There’s a certain number of patients who come ... also suggests that esketamine nasal spray doesn’t affect thinking skills the way high doses of ketamine do. What’s Next Along with ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for bumetanide nasal spray (RSQ-777 ... use outpatient therapy for patients with fluid overload.

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

Share on Pinterest The FDA has approved an esketamine nasal ... ketamine. “Hopefully, this approval by the FDA shows that there is sufficient evidence for esketamine working that providers and ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment ... “This approval gives patients and healthcare professionals the freedom to further ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression ... The Institute for Clinical and Economic Review (ICER) has published its final report on Spravato ...

People in Phoenix suffering from severe depression now have a Ketamine-derived nasal spray available for treatment. The feds proposed ending pay workers with disabilities getting paid less than ...

GSK (NYSE:GSK) announced Tuesday that the EU drug regulator has agreed to review ... nasal polyps (CRSwNP) in adults. The company seeks its approval as an add-on maintenance treatment for patients ...

to seek advice on whether ketamine should be reclassified as a Class A drug. Ms Allen, who is joint lead for addictions and substance misuse on behalf of the Association of Police and Crime ...